« Zarqawi network appeals for help in first signals of defeat | Main | Blogger in Ukraine Posts: My mother-in-law, revolutionary »

November 27, 2004

Bayer's Baycol Should Have Been Withdrawn Earlier

Topics: Clinical Pharmacology

Reported in Medical News Today

A new study indicates that a Bayer statin drug called 'Baycol' should have been taken off the market earlier. Statins are drugs that lower your cholesterol level.

Diabetic elderly people who take the drug along with fibrates have a much higher risk of developing a muscle disorder. Fibrates are drugs which lower your triglycerides.

Baycol was withdrawn in 2001 after some people who took it developed a severe muscle disorder which can sometimes be fatal.

According to a new study, the risks were much greater than had been thought.

You will be able to read about this study on December 1st issue in the Journal of the American Medical Association.   Source...

Posted by Hyscience at November 27, 2004 10:53 PM

Articles Related to Clinical Pharmacology:

• Britain tests first Cannabis related medicine for rheumatoid arthritis - Nov 13, 2005
• Experimental human monoclonal antibody shows striking benefit in patients with advanced melanoma - May 26, 2005
• Cystatin C May Push Creatinine Off Risk Radar - May 19, 2005
• Cancer Treatment Success Stuns Scientists - May 16, 2005
• Antibody, cancer drug combo shows promise against breast tumors - May 16, 2005
• USC researchers determine mechanism of action of motexafin gadolinium (Xcytrin) - May 02, 2005
• Herceptin® Combined With Chemotherapy Improves Disease-Free Survival for Patients With Early-Stage Breast Cancer - Apr 26, 2005
• Selenium will have critical role in prostate cancer treatment - Fox Chase Cancer Center - Apr 21, 2005
• Traditional Medicine Derivatives Kill Cancer Cells - Apr 20, 2005
• Compound from Chinese medicine shows promise in head and neck cancer, U-M study finds - Apr 19, 2005